Delivery Order SPE2D020D0014-SPE2D325F062J

Award Date 5/15/25
Potential Completion Date 5/20/25
Potential Value $8.5K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $2,820.00 and is a firm fixed-price contract. The ultimate completion date is April 16, 2025. This contract does not utilize a small business set-aside. Pfizer is a significant prime contractor for the federal government, holding several Indefinite Delivery Vehicle...
This is a firm-fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc. for the supply of Naloxone 4 mg/10 ml vials. The contract has a ceiling value of $11,280.00 and a completion date of September 24, 2024. This delivery order was awarded without the use of any set-aside designations. Pfizer is a large pharmaceutical corporation that serves as a prime contractor to various federal agencies, providing a wide range of pharmaceutical products,...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical, a defense agency, to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of Naloxone 0.4 mg/ml vials, a critical medication used to reverse opioid overdoses. The contract has a firm fixed price of $1,809.60 and a completion date of December 16, 2024. The contract was awarded without a set-aside designation, reflecting Pfizer's status as a large corporation. As a major...
This is a $59,220.00 firm fixed price delivery order contract awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of 4 mg/10 mL vials of Naloxone, an opioid overdose reversal medication. The contract has an ultimate completion date of February 27, 2025 and does not utilize any small business set-aside. Pfizer holds significant federal contract vehicles with the Department of Veterans Affairs, Centers for Disease...
This is a federal delivery order contract awarded by the Medical Supply Chain, a component of the Defense Logistics Agency Troop Support, to Pfizer Inc. The contract is for the supply of 4 mg/10 ml vials of the opioid overdose reversal drug Naloxone, with a ceiling value of $2,820. The contract is a firm-fixed price arrangement with a period of performance extending through February 27, 2025. This contract is not designated as a small business set-aside. Pfizer is a large, for-profit...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALOXONE 10MG/0.4ML, a critical pharmaceutical product, with a ceiling value of $11,763.28 and a period of performance through October 2023. The contract represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,915,829 units of Naloxone 2 mg/2 mL syringes. The contract has a firm fixed price of $1,888.60 and a performance period ending on January 14, 2025. It is not designated as a set-aside contract. The contract is awarded under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4 mg Naloxone HCl nasal spray. The contract has a ceiling value of $1,304.16 and a performance period through February 4, 2025. It is a firm-fixed-price contract type. The contract is not associated with a set-aside program. It appears to be part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the procurement of 4,566,756,418 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdose. The contract has a ceiling value of $1,557.70 and a period of performance through December 19, 2024. It is a firm-fixed-price delivery order contract,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of naloxone 0.4 mg/ml vials. The contract has a total ceiling value of $1,761.46 and is a firm fixed-price type contract. The period of performance extends through June 21, 2024. This award does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2D020D0014
    Indefinite Delivery Contract
  • SPE2D020D0014-SPE2D325F062J
    Delivery Order

This is a firm fixed-price delivery order awarded by the Medical Supply Chain, a defense agency, to Pfizer Inc., a large pharmaceutical manufacturer, for the supply of 4568256080 NALOXONE 4 MG/10 ML VIAL 10ML. The contract has a ceiling value of $8,460.00 and a period of performance ending on May 20, 2025. The award date is May 15, 2025. This contract is not set-aside for small businesses.

Pfizer is an established prime contractor that holds significant federal contract vehicles, including a $46,893,140 contract for Bevacizumab injections and a $2,007,801,000 Vaccines for Children (VFC) program contract with the Centers for Disease Control and Prevention. These contracts demonstrate Pfizer's extensive capabilities in supplying a wide range of critical pharmaceutical products to various government healthcare programs, including the Department of Veterans Affairs, Department of Defense, and public health initiatives.

Generated 8/14/25, 10:02 AM